Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1985 Apr 1;227(1):277–286. doi: 10.1042/bj2270277

Differential haemin-mediated restoration of cytochrome P-450 N-demethylases after inactivation by allylisopropylacetamide.

L M Bornheim, A N Kotake, M A Correia
PMCID: PMC1144837  PMID: 3994685

Abstract

Administration of allylisopropylacetamide (AIA) to phenobarbital-pretreated rats results in the destruction of several phenobarbital-inducible cytochrome P-450 isoenzymes and a correspondingly marked loss of benzphetamine N-demethylase and ethylmorphine N-demethylase activities. Accordingly, the ion-exchange h.p.l.c. or DEAE-cellulose-chromatographic profile of solubilized microsomal preparations from such rats revealed a marked decrease in the cytochrome P-450 content of several eluted fractions compared with that of microsomes from corresponding non-AIA-treated controls. Incubation of liver homogenates from such rats with haemin restores not only cytochrome P-450 content from 35 to 62% of original values, but also benzphetamine N-demethylase and ethylmorphine N-demethylase activities, from 23 to 67%, and from 12 to 36% of original values respectively. Moreover, the chromatographic profiles of microsomes prepared from such homogenates indicated increases of cytochrome P-450 content only in some fractions. Reconstitution of mixed-function oxidase activity of cytochrome P-450 by addition of NADPH: cytochrome P-450 reductase to these fractions indicated that incubation with haemin restored benzphetamine N-demethylase activity predominantly, but ethylmorphine N-demethylase activity only minimally. After injection of [14C]AIA, a significant amount of radiolabel was found covalently bound to protein in chromatographic fraction III, and this binding was unaffected by incubation with haemin. Furthermore, the extent of this binding is apparently equimolar to the amount of cytochrome P-450 refractory to haemin reconstitution in that particular fraction. Whether such refractoriness reflects structural inactivation of the apo-cytochrome remains to be determined. Nevertheless, the evidence presented very strongly argues for AIA-mediated inactivation of multiple phenobarbital-induced isoenzymes, only a few of which are structurally and functionally reparable by haemin.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aharonov A., Pruss R. M., Herschman H. R. Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. J Biol Chem. 1978 Jun 10;253(11):3970–3977. [PubMed] [Google Scholar]
  2. Bhat K. S., Sardana M. K., Padmanaban G. Role of haem in the synthesis and assembly of cytochrome P-450. Biochem J. 1977 May 15;164(2):295–303. doi: 10.1042/bj1640295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bonkovsky H. L., Sinclair J. F., Healey J. F., Sinclair P. R., Smith E. L. Formation of cytochrome P-450 containing haem or cobalt-protoporphyrin in liver homogenates of rats treated with phenobarbital and allylisopropylacetamide. Biochem J. 1984 Sep 1;222(2):453–462. doi: 10.1042/bj2220453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bornheim L. M., Franklin M. R. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction. Mol Pharmacol. 1982 Mar;21(2):527–532. [PubMed] [Google Scholar]
  5. Chung L. W., Chao H. Neonatal imprinting and hepatic cytochrome P-450. I. Comparison of testosterone hydroxylation in a reconstituted system between neonatally imprinted and nonimprinted rats. Mol Pharmacol. 1980 Nov;18(3):543–549. [PubMed] [Google Scholar]
  6. Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
  7. Correia M. A., Farrell G. C., Olson S., Wong J. S., Schmid R., Ortiz de Montellano P. R., Beilan H. S., Kunze K. L., Mico B. A. Cytochrome P-450 heme moiety. The specific target in drug-induced heme alkylation. J Biol Chem. 1981 Jun 10;256(11):5466–5470. [PubMed] [Google Scholar]
  8. Correia M. A., Meyer U. A. Apocytochrome P-450: reconstitution of functional cytochrome with hemin in vitro. Proc Natl Acad Sci U S A. 1975 Jan;72(1):400–404. doi: 10.1073/pnas.72.1.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. De Matteis F. Drug-induced destruction of cytochrome P-450. Drug Metab Dispos. 1973 Jan-Feb;1(1):267–274. [PubMed] [Google Scholar]
  10. De Matteis F., Gibbs A. H., Hollands C. N-alkylation of the haem moiety of cytochrome P-450 caused by substituted dihydropyridines. Preferential attack of different pyrrole nitrogen atoms after induction of various cytochrome P-450 isoenzymes. Biochem J. 1983 May 1;211(2):455–461. doi: 10.1042/bj2110455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. De Matteis F. Loss of haem in rat liver caused by the porphyrogenic agent 2-allyl-2-isopropylacetamide. Biochem J. 1971 Oct;124(4):767–777. doi: 10.1042/bj1240767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. De Matteis F. Rapid loss of cytochrome P-450 and haem caused in the liver microsomes by the porphyrogenic agent 2-allyl-2-isopropylacetamide. FEBS Lett. 1970 Feb 25;6(4):343–345. doi: 10.1016/0014-5793(70)80094-1. [DOI] [PubMed] [Google Scholar]
  13. Farrell G. C., Correia M. A. Structural and functional reconstitution of hepatic cytochrome P-450 in vivo. Reversal of allylisopropylacetamide-mediated destruction of the hemoprotein by exogenous heme. J Biol Chem. 1980 Nov 10;255(21):10128–10133. [PubMed] [Google Scholar]
  14. Farrell G. C., Schmid R., Kunze K. L., Ortiz de Montellano P. R. Exogenous heme restores in vivo functional capacity of hepatic cytochrome P-450 destroyed by allylisopropylacetamide. Biochem Biophys Res Commun. 1979 Jul 27;89(2):456–463. doi: 10.1016/0006-291x(79)90651-x. [DOI] [PubMed] [Google Scholar]
  15. Garewal H. S. A procedure for the estimation of microgram quantities of triton X-100. Anal Biochem. 1973 Aug;54(2):319–324. doi: 10.1016/0003-2697(73)90359-x. [DOI] [PubMed] [Google Scholar]
  16. Gillette J. R., Davis D. C., Sasame H. A. Cytochrome P-450 and its role in drug metabolism. Annu Rev Pharmacol. 1972;12:57–84. doi: 10.1146/annurev.pa.12.040172.000421. [DOI] [PubMed] [Google Scholar]
  17. Guengerich F. P. Comparison of highly-purified microsomal cytochromes P-450 and NADPH-cytochrome P-450 reductases by peptide mapping. Biochem Biophys Res Commun. 1978 Jun 14;82(3):820–827. doi: 10.1016/0006-291x(78)90856-2. [DOI] [PubMed] [Google Scholar]
  18. Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry. 1982 Nov 9;21(23):6019–6030. doi: 10.1021/bi00266a045. [DOI] [PubMed] [Google Scholar]
  19. Holloway P. W. A simple procedure for removal of Triton X-100 from protein samples. Anal Biochem. 1973 May;53(1):304–308. doi: 10.1016/0003-2697(73)90436-3. [DOI] [PubMed] [Google Scholar]
  20. Johnson E. F. Isolation and characterization of a constitutive form of rabbit liver microsomal cytochrome P-450. J Biol Chem. 1980 Jan 10;255(1):304–309. [PubMed] [Google Scholar]
  21. Koop D. R., Persson A. V., Coon M. J. Properties of electrophoretically homogeneous constitutive forms of liver microsomal cytochrome P-450. J Biol Chem. 1981 Oct 25;256(20):10704–10711. [PubMed] [Google Scholar]
  22. Kotake A. N., Funae Y. High-performance liquid chromatography technique for resolving multiple forms of hepatic membrane-bound cytochrome P-450. Proc Natl Acad Sci U S A. 1980 Nov;77(11):6473–6475. doi: 10.1073/pnas.77.11.6473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kunze K. L., Mangold B. L., Wheeler C., Beilan H. S., Ortiz de Montellano P. R. The cytochrome P-450 active site. Regiospecificity of prosthetic heme alkylation by olefins and acetylenes. J Biol Chem. 1983 Apr 10;258(7):4202–4207. [PubMed] [Google Scholar]
  24. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  25. Liem H. H., Johnson E. F., Muller-Eberhard U. The effect in vivo and in vitro of allylisopropylacetamide on the content of hepatic microsomal cytochrome P-450 2 of phenobarbital treated rabbits. Biochem Biophys Res Commun. 1983 Mar 29;111(3):926–932. doi: 10.1016/0006-291x(83)91388-8. [DOI] [PubMed] [Google Scholar]
  26. Loosemore M. J., Wogan G. N., Walsh C. Determination of partition ratios for allylisopropylacetamide during suicidal processing by a phenobarbital-induced cytochrome P-450 isozyme from rat liver. J Biol Chem. 1981 Aug 25;256(16):8705–8712. [PubMed] [Google Scholar]
  27. Lu A. Y., West S. B. Multiplicity of mammalian microsomal cytochromes P-45. Pharmacol Rev. 1979 Dec;31(4):277–295. [PubMed] [Google Scholar]
  28. NASH T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J. 1953 Oct;55(3):416–421. doi: 10.1042/bj0550416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Oritz de Montellano P. R., Correia M. A. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol. 1983;23:481–503. doi: 10.1146/annurev.pa.23.040183.002405. [DOI] [PubMed] [Google Scholar]
  30. Ortiz de Montellano P. R., Mico B. A. Destruction of cytochrome P-450 by allylisopropylacetamide is a suicidal process. Arch Biochem Biophys. 1981 Jan;206(1):43–50. doi: 10.1016/0003-9861(81)90063-1. [DOI] [PubMed] [Google Scholar]
  31. Ortiz de Montellano P. R., Mico B. A. Destruction of cytochrome P-450 by ethylene and other olefins. Mol Pharmacol. 1980 Jul;18(1):128–135. [PubMed] [Google Scholar]
  32. Ryan D. E., Thomas P. E., Levin W. Hepatic microsomal cytochrome P-450 from rats treated with isosafrole. Purification and characterization of four enzymic forms. J Biol Chem. 1980 Aug 25;255(16):7941–7955. [PubMed] [Google Scholar]
  33. Smith A. The metabolism of 2-allyl-2-isopropylacetamide in vivo and in the isolated perfused rat liver. Biochem Pharmacol. 1976 Nov 15;25(22):2429–2442. doi: 10.1016/0006-2952(76)90445-7. [DOI] [PubMed] [Google Scholar]
  34. Wada O., Yano Y., Urata G., Nakao K. Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem Pharmacol. 1968 Apr;17(4):595–603. doi: 10.1016/0006-2952(68)90275-x. [DOI] [PubMed] [Google Scholar]
  35. Warner M., LaMarca M. V., Neims A. H. Chromatographic and electrophoretic heterogeneity of the cytochromes P-450 solubilized from untreated rat liver. Drug Metab Dispos. 1978 Jul-Aug;6(4):353–362. [PubMed] [Google Scholar]
  36. Waxman D. J., Walsh C. Phenobarbital-induced rat liver cytochrome P-450. Purification and characterization of two closely related isozymic forms. J Biol Chem. 1982 Sep 10;257(17):10446–10457. [PubMed] [Google Scholar]
  37. Yasukochi Y., Masters B. S. Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem. 1976 Sep 10;251(17):5337–5344. [PubMed] [Google Scholar]
  38. Yu C., Gunsalus I. C. Cytochrome P-450cam. II. Interconversion with P-420. J Biol Chem. 1974 Jan 10;249(1):102–106. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES